FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma

Accurate prediction of the outcome of molecular target-based treatment in advanced renal cell carcinoma (RCC) is an important clinical problem. Positron emission tomography/computed tomography using [18F]-2-fluoro-2-deoxyglucose (FDG PET/CT) is a noninvasive tool for the assessment of glucose accumu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pankowska, Violetta, Malkowski, Bogdan, Wedrowski, Mateusz, Wedrowska, Ewelina, Roszkowski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394561/
https://www.ncbi.nlm.nih.gov/pubmed/30488140
http://dx.doi.org/10.1007/s10238-018-0539-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394561/
https://www.ncbi.nlm.nih.gov/pubmed/30488140
http://dx.doi.org/10.1007/s10238-018-0539-9

Ejemplares similares